缺血性肠病的临床治疗及疗效评析.docVIP

缺血性肠病的临床治疗及疗效评析 　　【摘要】 目的：研究并探讨缺血性肠病的临床治疗方法及疗效。方法：于2013年1月-2015年6月，在笔者所在医院消化内科收治的缺血性肠病患者中随机抽取70例缺血性肠病患者作为研究对象，采取计算机随机抽取法将这70例患者分为对照组、观察组，每组35例。所有患者均在入院后立即给予常规综合治疗，对照组给予罂粟碱注射液治疗，观察组给予罂粟碱注射液+前列地尔注射液治疗。治疗结束后，对比两组患者的治疗效果和不良反应。结果：观察组的临床总有效率为94.29%，高于对照组的77.14%，差异有统计学意义（P0.05）。结论：在缺血性肠病的临床治疗中，采用罂粟碱和前列地尔联合治疗方案具有显著的临床治疗效果，同时，还具有较高的安全性。 　　【关键词】 缺血性肠病； 罂粟碱； 前列地尔； 治疗 　　中图分类号 R574 文献标识码 B 文章编号 1674-6805（2016）27-0015-02 　　Analysis of Clinical Treatment and Curative Effect of Ischemic Bowel Disease/YANG Qing-qing.//Chinese and Foreign Medical Research，2016，14（27）：15-16 　　【Abstract】 Objective：To study and explore the effective methods of clinical treatment of ischemic bowel disease.Method：From January 2013 to June 2015，70 cases of ischemic bowel disease patients in the digestive system department of our hospital were randomly selected as the research object，70 cases of patients were divided into control group and observation group according to the computer randomly selected method，with 35 patients in each group.All patients in the hospital were immediately given routine comprehensive treatment，the control group was treated with injection of Papaverine and the observation group was given Papaverine injection combined with Alprostadil injection treatment.After the end of treatment，the treatment effect and adverse reactions of the two groups were compared.Result：The total effective rate of the observation group was 94.29%，higher than 77.14% of the control group，the difference was statistically significant（P0.05）.Conclusion：In the clinical treatment of ischemic bowel disease，Papaverine and Alprostadil combination therapy has significant treatment effect，at the same time，it also has high security. 　　【Key words】 Ischemic bowel disease； Papaverine； Alprostadil； Treatment 　　First-author’s address：The People’s Hospital of Yubei District in Chongqing City，Chongqing 401120，China 　　doi：10.14033/j.cnki.cfmr.2016.27.007 　　缺血性肠病的病情较为凶险，如患者未能得到及时的治疗或疗效欠佳，很可能会发展为肠坏死、中毒性休克，危及患者生命安全[1]。